Can You Tell Down Syndrome From an Ultrasound?

No, an ultrasound alone cannot diagnose Down syndrome. It detects soft markers like nuchal translucency that suggest increased risk.

Most expecting parents look at the 20-week anatomy scan expecting a clear thumbs-up or thumbs-down on the baby’s health. When the topic is Down syndrome (trisomy 21), that expectation needs a meaningful caveat.

Ultrasound is a powerful screening tool, but it operates on probabilities, not absolutes. This article walks through what a prenatal scan can tell you, what soft markers really mean, and why the final answer often requires a different type of test.

How Prenatal Ultrasound Screens for Down Syndrome

A first-trimester ultrasound typically includes the nuchal translucency (NT) scan. This measures the clear fluid pocket at the back of the baby’s neck. An increased NT is considered a key early marker for trisomy 21.

The NT scan is ideally performed during the 12th week. It provides the most useful data between 11 weeks, 3 days and 14 weeks of pregnancy.

During the mid-pregnancy anatomy scan, usually completed between 18 and 22 weeks, sonographers evaluate the baby’s structure. They look for other soft markers such as an absent nasal bone, an enlarged nuchal fold, or certain heart findings.

These markers are not structural abnormalities themselves. They are observations that, when combined with other factors, may adjust the overall risk calculation for the pregnancy.

Why a Single Scan Can’t Give the Final Word

It’s natural to hope the ultrasound will deliver a firm yes or no, but several factors prevent that. Understanding these limitations helps set realistic expectations for the screening process.

• High False Positive Rate: Soft markers appear in about 5% of normal pregnancies. Using ultrasound alone creates many false alarms. One study noted that removing NT from combined screening would increase the false positive rate 5-fold to maintain detection levels.
• Operator Skill Matters: Measuring a 1-2mm difference in NT or identifying a missing nasal bone requires specific training and good equipment. Results can vary somewhat between clinics.
• Single Markers Have Less Weight: An isolated echogenic intracardiac focus (EIF) in a low-risk pregnancy has a very small impact on risk. Multiple markers or a very high NT carry more clinical weight.
• Screening vs. Diagnosis: This is the crucial distinction. Ultrasound is a risk-assessment tool. A definitive answer requires analyzing fetal cells, obtained via CVS at 10-13 weeks or amniocentesis at 15-20 weeks.

The goal of screening is to identify pregnancies that might benefit from more detailed evaluation, not to generate unnecessary worry about every minor finding.

Key Markers Doctors Look For

When someone asks what a Down syndrome ultrasound looks for, doctors focus on specific measurements in both the first and second trimesters. These markers are most meaningful when interpreted alongside blood screening results.

A 2025 review in the Journal of Maternal-Fetal Medicine confirms these as the core soft markers for trisomy 21. The quad screen, which measures AFP, hCG, estriol, and inhibin A in your blood, adds another layer. MedlinePlus provides a thorough breakdown of how these quad screen markers work in parallel with ultrasound findings.

The Path to a Confirmed Diagnosis

If ultrasound markers suggest an elevated risk, the next step follows a logical sequence. Each stage gathers more information before moving to invasive testing.

1. Combined First-Trimester Screening: NT measurement plus blood tests for PAPP-A and β-hCG. One review found this combination can detect around 89% of cases with a 5% false positive rate.
2. Second-Trimester Quad Screen: A blood test checking four specific substances. This is often used if first-trimester screening wasn’t completed.
3. Cell-Free DNA (cfDNA/NIPT): A blood test that screens fetal DNA circulating in the mother’s blood. It has high detection rates for trisomy 21.
4. Diagnostic Testing: CVS or amniocentesis. These carry a small risk of miscarriage but provide a definitive answer by analyzing the baby’s chromosomes.

Your provider uses this sequence to refine the risk picture. Each step adds clarity before deciding whether invasive testing is appropriate.

Interpreting Soft Markers and Next Steps

Seeing a soft marker on a report can feel unsettling, but context matters. A single soft marker in a low-risk pregnancy has a minimal impact on overall odds. Multiple markers or a very high NT shift the risk picture more significantly.

For example, an absent nasal bone is a specific finding. Healthline’s resource on the absent nasal bone marker explains that while it raises the calculated risk, it is considered a soft marker rather than a definite structural problem.

The purpose of ultrasound screening is not to create anxiety but to identify pregnancies that could benefit from more detailed evaluation. A clear plan for follow-up is part of the process.

The Bottom Line

Ultrasound is an essential screening tool, but it cannot deliver a definitive diagnosis of Down syndrome on its own. It can detect soft markers that adjust your risk level. The most accurate prenatal picture typically comes from combining NT measurement, blood chemistry, and anatomy scan findings together.

If your results show soft markers, a genetic counselor or maternal-fetal medicine specialist can help you understand the specific numbers and decide whether diagnostic testing like CVS or amniocentesis aligns with your needs.